The acidic extracellular environment of tumors potentiates their aggressiveness and metastasis, but few methods exist to selectively modulate the extracellular pH (pHe) environment of tumors. Transient flushing of biological systems with alkaline fluids or proton pump inhibitors is impractical and nonselective. Here we report a nanoparticles-based strategy to intentionally modulate the pHe in tumors. Biochemical simulations indicate that the dissolution of calcium carbonate nanoparticles (nano-CaCO3) dissolution in vivo increases pH asymptotically to 7.4. We developed two independent facile methods to synthesize monodisperse non-doped vaterite nano-CaCO3 with distinct size range between 20 and 300 nm. Using murine models of cancer, we demonstrate that the selective accumulation of nano-CaCO3 in tumors increases tumor pH over time. The associated induction of tumor growth stasis is putatively interpreted as a pHe increase. This study establishes an approach to prepare nano-CaCO3 over a wide particle size range, a formulation that stabilizes the nanomaterials in aqueous solutions, and a pH-sensitive nanoplatform capable of modulating the acidic environment of cancer for potential therapeutic benefits.
Introduction
The current understanding of cancer development has evolved from a simple view of uncontrolled growth stemming from gene mutation within a single cell to that of complex interactions between different cell types and their local chemical environment. In particular, the 4-5 fold increase in the extracellular hydrogen ion concentration around tumor cells, previously considered a byproduct of upregulated glycolysis, appears to support elevated tumor growth, immune evasion, and metastasis. [1] [2] [3] [4] [5] To combat these effects, various cancer therapies focusing on modulating extracellular pH (pHe) of tumors have been investigated. 6 For instance, intracellular modulators of intrinsic proton transport and production such as proton pump and carbonic anhydrase IX inhibitors have inhibited tumor growth by increasing pH in vivo. 1, 6, 7 However, the intracellular targets of these drugs are expressed in non-cancerous cells and therefore can have off-target toxic effects. 7 In addition, redundancy of intracellular pathways can lead to drug resistance and loss of therapeutic efficacy over time. 8, 9 To avoid intracellular resistance pathways, dietary alterations including sodium bicarbonate can raise the systemic extracellular pH. 2 Although a positive response has been observed in some tumors, this approach requires the administration of large amounts of the salt, does not target the tumors directly, has a transient effect on tumor pHe because of the rapid clearance from circulation, and is expected to induce metabolic alkalosis, and consequent morbidity. 10 An alternative approach to directly modulate the acidic pHe of tumors is to develop nanoparticle delivery vehicles with sustainable buffering capacity. This approach could minimize the drug resistance potential seen in intracellular therapies, but also add the selectivity seen with nanotechnology. 11 Cationic secondary amine dendrimers have been used to respond to acidic pH, mainly to escape the lysosome, for intracellular drug delivery. 12 However, dendrimers are capable of neutralizing only a small number of protons (10 −20 mole) per nanoparticle, thereby limiting their buffering capacity. Unless a nondesirable continuous infusion of the polyamine nanoparticles is used, their buffering capacity is not regenerative, and the products of amine protonation could induce off-target toxicity. Inorganic nanoparticles, such as doped CaCO 3 , have been used for acid sensitive drug release. 13, 14 However, rarely has any biocompatible inorganic nanoparticle been intentionally designed and used to modulate tumor pHe.
In this work, we developed methods to prepare monodisperse nano-CaCO 3 with size ranges from 20 -300 nm. We also identified a method to stabilize the materials in aqueous media. Simulations and in vitro testing show that regenerative buffering capacity is obtained because the products of this interaction, water and bicarbonate, dissociate from the bulk nanoparticle core, creating a new surface to neutralize additional protons produced by the cells. In addition, we demonstrate that nano-CaCO 3 with distinct sizes can selectively localize in the extracellular region of tumors and modulate tumor pH in rodents, accompanied by the prevention or reduction of tumor growth ( Figure S1 ).
Results and discussion

Simulation of CaCO3 nanoparticle dissolution in vivo predicts asymptotic pH increase and buffering to pH 7.4
CaCO 3 is an important biomaterial that is widely available in different forms. Although CaCO 3 solutions can serve as buffering agents, a saturated aqueous solution of this salt has a predicted pK a of about 9, suggesting the potential to induce metabolic alkalosis in vivo. In the solid state, CaCO 3 exists predominantly as calcite, aragonite, or vaterite polymorphs. Each of these polymorphs differs in their crystal lattice structure. Unlike calcite and aragonite, which are not soluble in aqueous medium, vaterite is more soluble because of its low thermodynamic stability compared to the other polymorphs found in nature. For our intended application, slow but consistent dissolution in mildly acidic solutions is an essential criterion for a regenerative pHe buffering agent. To prevent metabolic alkalosis in surrounding healthy tissue, the preferred material should only increase the pH to about 7.4 (normal body pH).
Because CaCO 3 dissolution is regulated by basic rate equations, a simulation of its dissolution and prediction of the expected pH changes in vivo and in vitro is possible ( Figure   1 ). Dissolution of CaCO 3 under mildly acidic conditions follows several steps:
Generation of carbonate in equation (1) drives CaCO 3 dissolution under acidic pH conditions following L'Chatelier's principle. Previous studies have modeled the pH changes in response to CaCO 3 dissolution in an aqueous medium. 15 Adapting this model to a tissue cylinder approach (Figure 1a ), we derived the following equations:
The solubility of CaCO 3 (C b ) is a function of the solubility product (K sp ), pH, and the equilibrium constants (K a1 and K a2 ). Change in concentration of CaCO 3 is a function of the CaCO 3 concentration (C s ), the solubility (C b ), the surface area (A), the diffusion distance (d), and volume (V). The radius of the particle (r p ) is additionally dependent on the density of CaCO 3 (ρ) The change in pH is also dependent on the buffering constant, and approximates A/V as 1/L, where L is the length of the tissue cylinder. Using equations (2) (3) (4) , an equilibration point occurs for dissolving CaCO 3 at a pH of 7.4 ( Figure 1b ). This suggests that CaCO 3 will only increase pH in acidic environments such as those found in the pHe of solid tumors and that this process is unlikely to induce metabolic alkalosis because the pH will not exceed 7.4.
To visualize this process in a 3D model, we modeled nano-CaCO 3 diffusion in a tissue matrix using a tissue cylinder model (Figure 1a) , where a single capillary is assumed to feed a tissue cylinder. From this model, we derived the equation for the distribution of CaCO 3 in the tissue cylinder as a function of the radius (r), capillary radius (r c ), diffusion coefficient of CaCO 3 (D c ), the partition coefficient (k), degradation rate (R cmax ), and the influx dose (C d ) as follows:
The diffusion coefficient (D c ) of the particle in tissue, which is dependent on particle size, was estimated using the Renkin equation. 16 We also derived the initial pH distribution from diffusion of protons from the capillary to be the following as a function of the rate of proton production (R pmax ), diffusion of the proton (D p ), radius (r), and capillary radius (r c ): (6) The change in proton concentration is thus determined by numerically solving equations (2), (4), and (6) by iteration. Similarly, CaCO 3 concentrations can be calculated by using a combination of equations (2), (3), and (5) over the associated tissue cylinder. We find that the CaCO 3 concentrations are relatively constant over time, predicting a slow dissolution process ( Figure 1c ). In addition, the simulation predicts that the pH does not exceed its maximum of 7.4 by 24 h (Figure 1d ). This profile predicts that in vivo CaCO 3 dissolution is acid selective and therefore is an ideal nanomaterial for modulating the acidic pHe of solid tumors. Additional information on the derivation of the equations and model assumptions can be found in the supplementary information.
Independent facile synthetic methods produce pure vaterite nanoparticles with controlled size range from 20 -300 nm
The malformation of blood and drainage vessels around solid tumors creates an environment for the selective retention of nanoparticles through the enhanced permeation and retention (EPR) effect. 17 Typically, materials with core diameters less than 500 nm are preferred to enhance intravascular dynamics and diffusion to tumor cells further from the blood vessels. 11, 17 Unfortunately, CaCO 3 nanoparticles that are stable in aqueous solutions have been difficult to synthesize at sub-micron sizes without the use of harsh conditions (custom high pressure systems), doping materials (lipid-based surfactants), other additives such as phosphate, polystyrene, and drugs, or a combination of calcium phosphate and calcium carbonate. 13, 14, [18] [19] [20] Attempts to prepare pure nano-CaCO 3 have generally resulted in the production of materials with core diameter > 500 nm [21] [22] [23] due to difficulty in controlling the particle's growth. Furthermore, CaCO 3 nanoparticles can rapidly grow to larger crystalline polymorphs (calcite, vaterite, or aragonite) when placed under aqueous conditions via a variety of mechanisms. [24] [25] [26] [27] [28] Building on literature methods, we have identified two independent methods to produce pristine sub-micron vaterite nano-CaCO 3 with distinct size ranges at 20 nm, 100 nm, and 300 nm. Synthesis of the 100 nm nano-CaCO 3 was accomplished by using a gas diffusion method ( Figure S2 , Methods section). 24 The stepwise approach of exposing calcium chloride in anhydrous ethanol to controlled amounts of ammonium bicarbonate, followed by gradual air drying of the product, afforded a simple and highly reproducible method to prepare these nanoparticles. To provide flexibility in particle size, we used a double decomposition reaction method between hydrated calcium chloride and sodium bicarbonate at room temperature. Size control was achieved by mixing the reactants in a mixture of solvents consisting of 1:5 ratio of water/polyethylene glycol (20 nm) and water/ethylene glycol (300 nm). The ethylene glycol and polyethylene glycol were used to modulate the diffusion rate of calcium and carbonate ions, thereby controlling nucleation and growth by particle cluster formation. 29, 30 This approach revealed that solvent viscosity can serve as a modular strategy to prepare pure vaterite nanoparticles.
The size and morphology of synthesized nano-CaCO 3 were determined by transmission electron microscopy (TEM) and dynamic light scattering (DLS) ( Figure 2 ). Typical TEM micrographs revealed that nano-CaCO 3 were primarily spherical, as expected for vaterite. The geometric mean diameters of the nano-CaCO 3 were 20 ± 1.4 nm, 100 ± 8.3 nm and 300 ± 14.6 nm (Figure 2a -c). Expectedly, DLS revealed a slight increase in the hydrodynamic diameter (Dh) for all particle sizes because of the interaction of solvent molecules with the surface of particles, creating a thin layer of solvent molecules ( Figure 2d ). However, two peaks were observed in the DLS profile of the 20 nm nanoparticles, in which one peak exhibited smaller Dh than the physical diameter. These peaks could arise from the asymmetric shape of the particles, as shown in the 20 nm particles (Figure 2a ). 31 Larger sizes were typically spherical, accounting for the lack of a second smaller peak. Irrespective of the synthesis method, all three sizes of the nano-CaCO 3 showed peaks at theta angles of 24.8, 27.1, 32.8 and 43.9, which are consistent with the characteristic hexagonal vaterite crystalline structure of CaCO 3 (Figure 2e & Figure S3 ). Because vaterite is more soluble in aqueous media than other CaCO 3 polymorphs, these materials are suitable for use in alkalinizing the acidic pHe of tumors if they can remain stable in aqueous environments without rapidly converting to the less soluble calcite.
Albumin prevents rapid conversion of vaterite nanoparticles to calcite or calcium phosphate in aqueous medium and serum
The solubility and stability of these vaterite nanoparticles are critical for successful biological applications in vivo. We explored a variety of biologically compatible media to identify the optimal storage conditions and vector for intravenous (I.V.) administration of the nano-CaCO 3 (Figure 3 ; Figure S4 ). DLS analysis shows a rapid increase of the 100 nm vaterite nanoparticles from 100 nm to over 500 nm within a few seconds in saline and phosphate buffered saline (PBS; Figure 3a ). The observed morphological change in PBS could be attributed to calcite or CaPO 4 formation. However, the addition of 2% albumin in PBS remarkably stabilized the materials for extended periods, demonstrating the potential of formulating vaterite nanoparticles in this medium for I.V. administration (Figure 3a ,b). A similar trend was observed with the 20 nm and 300 nm nano-CaCO 3 ( Figure S5 ).
We further determined the long-term particle stability in different media for up to 7 h. Timeresolved DLS (TR-DLS) suggests that the particles in aqueous albumin-containing solution exist in pairs of 2 or 3 (size 2-3 times larger than in ethanol), which dissociate into individual particles upon exposure to fetal serum (Figure 3a , Figure S5 ). TEM confirmed the high stability of the particles in albumin solution (Figure 3b , Figure S5 ). X-Ray Diffraction (XRD) analysis did not show any change in crystallinity in albumin-based aqueous media ( Figure 3c ). The nano-CaCO 3 exhibited stability in both morphology and size in fetal bovine serum (Figure 3d , Figure 5 ).
These results suggest that albumin, which has a high affinity for calcium, 32 serves as a calcium sink that prevents aggregation and calcium phosphate formation in PBS. The minimal change in TEM (structural) and X-ray diffraction (crystalline) analyses confirms that extensive double replacement to form CaPO 4 did not occur. In general, clusters of three nano-CaCO 3 form in albumin solutions, which separate into single particle serum is added to the mixture. The additional serum stability conferred on nano-CaCO 3 in aqueous albumin solution indicates that pre-formulation of the nanoparticles in this medium is ideal for in vivo application, where serum is abundant.
Efficacy of modulating the acidic pH of tumors in vivo depends on CaCO 3 nanoparticle size
Predicated on the simulation studies, we assessed the buffering capacity of the nanoparticles in cell-free media under 5% CO 2 and hypoxic (0.3% O 2 ) conditions ( Figure 4a ). In nonacidified conditioned media (pH 7.4), the solution pH was largely unchanged in the presence of different sizes and concentrations of vaterite nano-CaCO 3 , as predicted by simulations above. However, treatment of acidic conditioned media (pH 6.2) with any of the particles (0.67 mg/mL) showed a rapid increase in pH, which did not exceed 7.2. Similarly, the pH remained at about pH 7.2 after 24 h incubation of human fibrosarcoma (HT1080) cells in normal cell culture conditions, irrespective of the nanoparticle doses used (Figure 4b ). At 96 h post HT1080 cellular induced acidification, nanoparticle size-dependent pH changes were observed, with the 20 nm materials having the highest increase in pH. This trend could be attributable to the higher diffusion rate and the larger surface area of the 20 nm nano-CaCO 3 .
Despite recent advances in noninvasive methods to measure pH, they still suffer from poor sensitivity to pHe and poor temporal resolution needed to measure the dynamic changes in pH. 33 Our initial attempt to determine tumor pHe by the reported 31 P NMR spectroscopic technique using 3-aminopropylphosphonate 34 was unsuccessful due to technical issues. To determine whether nano-CaCO3 was capable of altering pH in vivo, we used a 5 mm diameter invasive in vivo pH electrode probe (Figure 5a ), and putatively interpreted the resulting pH values as predominantly extracellular. Based on this technique Based on this technique, we find that a control vector administration resulted in a slight decrease in pH over time, possibly due to a variety of factors that may include cell lysis, blood vessel destruction, and inflammation from the probe injury. Against this background, I.V. administration of 1 mg bolus injections of each of the 3 types of nano-CaCO 3 in HT1080 tumor-bearing mice increased the tumor pH for over 3 h at varying amounts. The 100 nm nano-CaCO 3 showed the highest ΔpH and longest effect (Figure 5b ). The 20 nm particles appeared to diffuse into and out of the tumor area more rapidly than the 100 nm particles.
Intuitively, larger particles are expected to exert higher response because of their favorable EPR effect. However, the 300 nm nano-CaCO 3 do not appear to appreciably increase the pH of tumors. The poor diffusion of these particles dictates that they can only exert an effect in a small section of a three-dimensional tumor environment. Our data also show that flooding the mouse with a high concentration (0.3 -0.4 g/Kg) of sodium bicarbonate (~10x the nanoparticle I.V. dosage) did not induce a measurable pH change in the tumor region ( Figure  5b ), which may be due to rapid clearing by the kidney and lungs.
Transient alkalinization of the acidic pHe can inhibit tumor growth
The effect of persistent alkalinization of the acidic pHe of solid tumors is not known at this time. Dynamic pH measurements in mice bearing HT1080 tumors indicate that 100 nm sized nanoparticles administered at a bolus dose of 1 mg (0.04-0.05 g/kg body weight) almost linearly increases the pH during the first 30 minutes, followed by a decrease at about 100 minutes. Repeated dosing at selected time points can maintain the pH close to 7.4 (Figure 5c ), which matches the expectations of our simulation (Figure 1 ).
Consistent with our hypothesis, we found that repeated daily administration of nano-CaCO 3 significantly inhibited tumor growth (Figure 6a,b) . Further, discontinuation of the nano-CaCO 3 treatment partially reversed this trend, resulting in the acceleration of tumor growth rate (Figure 6c,d) . This finding suggest the potential of tumor cell reprograming in response to an initial assault by nano-CaCO 3 . Future studies will explore this concept. Our results suggest that if a therapeutic outcome using this method is envisaged, multiple doses of nano-CaCO 3 may be required to sustain the alkalinizing effect until either depletion of the nanoparticles or reprogramming of the tumor cells in response to treatment. To achieve a sustainable tumor-inhibitory effect, it will be necessary to optimize dosing, combine nano-CaCO 3 with other therapies, and improve targeting of the nano-CaCO 3 to tumors.
Conclusions
We have identified a facile, scalable method for mass production of sub-micron vaterite calcium carbonate nanoparticles that are stable in biological media. Two different methods wherein particle nucleation and cluster growth could be effectively controlled was demonstrated to obtain the desired size ranges and crystal phases of calcium carbonate nanoparticles. For the first time, we have demonstrated the capability of modulating the pH in vivo of solid tumors using nano-CaCO 3 . Efficient alkalinization of the acidic pH of tumors depends on particle size. Our results suggest that large (> 300 nm) and small (< 20 nm) particles are less effective in increasing the in vivo pH because of limited diffusion and transient retention in the tumor environment, respectively. The ability of nano-CaCO 3 to inhibit tumor growth in vivo could serve as a treatment paradigm for long-term tumor static therapy. Future studies will focus on dose optimization, enhancement of tumor-targeting capability, determination of synergistic treatments with complementary therapies, assessment of potential tumor cell reprogramming following nano-CaCO 3 treatment, and exploration of the effects of nano-CaCO 3 on metastatic growth. Although we did not observe any gross toxicity, multiple injections of the nanoparticles could alter the functional status of some enzymes or pH-sensitive tissues. Future studies will determine these potential effects in a dose escalation study. In addition, we putatively attributed the average pH values measured with the invasive pH electrode to predominantly the pHe of tumors. Validation of this assumption with a noninvasive method that measures the pHe of tumors more accurately 34 will be needed.
Experimental
Simulation of CaCO 3 dissolution in vivo
Simulations were run in MATLAB using a numerical iteration approximation. Equations (1-6) are derived from a tissue cylinder model of diffusion and diffusion of CaCO 3 from a nanoparticle under the conditions of constant infusion. Equations (5) and (6) were used to determine the initial CaCO 3 and pH distributions in the tissue cylinder model. Changes in CaCO 3 and pH were then numerically approximated using equations (3) and (4). Authors will provide code for the simulation upon on request. 
(3)
The solubility of CaCO 3 (C b ), in equation (2) is a function of pH, the solubility product (K sp ), and equilibrium constants K a1 and K a2, obtained from equations (1a, 1b). The rate of change in CaCO 3 concentration (C) and in particle radius (r), seen in equation (3) For equation (5) , R cmax was empirically determined by starting at the maximum degradation rate in the tissue at pH of 6.65 and then multiplying by a correction factor until the distribution of CaCO 3 appeared optimal, in this case approximately 0.5 mm from the capillary. The resulting degradation correction factor was used throughout for simulating CaCO 3 degradation. The radius of the capillary (r c ) was set at 10 μm. The partition coefficient (k) of the capillary is dependent on the capillary pore radius, estimated at 500 nm 
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Author Manuscript and particle radius, defined as 100 nm. The initial concentration of CaCO 3 (C d ) in the capillary was estimated as 5% of the infused concentration (set as 1 mg in a 20 g mouse).
R pmax was empirically determined as the point at which the average pH in the tissue was 6.65, identified as 0.0225 M/s. The diffusion coefficient (D p ) was estimated as the diffusion of a particle with a molecular weight of 1 Da in an extracellular matrix. We used the following constants for the simulation based on literature values or model assumptions: r = 50 nm, K a1 = 4.45*10 −7 , K a2 = 4.69*10 −11 , K sp = 6*10 −9 , M = 100.0869 g/mol, ρ = 2.71 g/mL.
Synthesis of 100 nm nano-CaCO 3
We synthesized 100 nm CaCO 3 nanoparticles using a gas diffusion method. CaCl 2 *6H 2 O (220 mg) was dissolved by vortexing in anhydrous ethanol (50 mL). The resulting solution was transferred to a 100 mL beaker covered with parafilm. After puncturing small holes in the parafilm, the beaker was placed in a desiccator (with drierite) surrounded by four 20 mL vials containing excess dry ammonium bicarbonate (~9-10 g). The entire system was placed under vacuum for 25 h. The particles were centrifuged at 6800 g for 10 min, excess ethanol decanted, and the residue was left to dry in the open air before use.
Synthesis of 20 and 300 nm CaCO 3
A double decomposition reaction was used to prepare the CaCO 3 particles by mixing 0.1 M each of CaCl 2 *2H 2 O and NaHCO 3 at room temperature. The premix solutions of CaCl 2 *2H 2 O and NaHCO 3 were prepared in water and polyethylene glycol (1:5 v/v; average molecular weight 1450 Da) for ~20 nm, and water and ethylene glycol (1:5 v/v; molecular weight 62.07 g/mol) for ~300 nm particles. The synthesized CaCO 3 particles were collected by sequentially washing the product with ethanol, methanol and acetone, followed by drying at 60 °C for 1 h.
Transmission Electron Microscope (TEM)
TEM micrographs were obtained using an FEI Spirit TEM (Hillsboro, USA) operated at 120 kV. A 400-mesh Formvar® carbon-coated copper grid was glow-discharged in a vacuum evaporator (Denton, Moorestown, New Jersey) for 30 s. The sample was prepared by placing 2 μL of sonicated CaCO 3 nanoparticles solution onto the grid and wicking off the excess sample with filter paper after 30 s. Alternatively, for EtOH or DMSO solvent-based solutions, 3 μL of particle solution were placed on the grid and left to dry out at room temperature or with the aid of a heat gun.
X-Ray Diffraction (XRD)
XRD patterns were obtained by using the Bruker d8 Advance X-ray Diffractometer (Bruker, USA) configured with a Cu X-Ray tube with 1.5418 Å for analysis of powder samples using LYNXEYE_XE detector. For the analysis, fine acetone ground CaCO 3 nanoparticles were kept on a Zero Diffraction Plate (MTI Corporation, USA). XRD data were scanned from 20-60 degrees, with a 0.04 degree step size, a 0.5 s per step count time, with sample rotation turned on (15 rotations per min), with a coupled two-theta/theta scan. The Bruker Diffrac.Eva program was used for the evaluation and processing of X-ray diffraction scan data. Search-match operations included search by DI list, by name, using chemistry filters, and creating an International Centre for Diffraction Data (ICCDD PDF) database filter.
Hydrodynamic diameter and electro-kinetic zeta potential
The To study agglomeration kinetics of CaCO 3 nanoparticles, hydrodynamic diameter (Dh) was measured using DLS (Malvern Instruments, Southborough, Massachusetts). Agglomeration kinetics were measured on the basis of data obtained from TR-DLS. The zeta potential was measured using a Malvern Zetasizer Nano ZS instrument. An applied voltage of 100 V was used for the nanoparticles. A minimum of three measurements were made per sample.
Identification of stable aqueous medium for nano-CaCO 3
Nano-CaCO 3 was resuspended in the following solvents: (1) dIH 2 O; (2) Dulbecco's PBS, 
Determination of pH change in acidic media versus normal media
We determined CaCO 3 dissolution over time by measuring pH changes in conditioned acidic media and fetal bovine serum. Conditioned media was from a 7 day incubation of media with HT1080 cells and an initial pH ~ 6.2. Final concentrations of CaCO 3 in the cell free solutions were controlled at 0.67 mg/mL. CaCO 3 was added to conditioned media or serum in ~10 μL of aqueous vector (PBS + CaCl 2 + MgCl 2 + 2% bovine serum albumin) under hypoxic 5% CO 2 conditions. The pH was then measured after 1 hThe main text of the article should appear here with headings as appropriate.
Determination of nano-CaCO 3 dose-dependent pH changes in HT1080 cell culture medium
HT1080 cells were plated at 10 5 cells/well in a 24 well plate overnight under hypoxic conditions (0.3% O 2 and 5% CO 2 ), and then incubated with increasing amounts of 20 nm, 100 nm and 300 nm particles for 24 and 96 h. The particles were directly added and resuspended in media via vortexing under hypoxic conditions (0.3% O 2 and 5% CO 2 ). The pH was measured after 24 and 96 h incubation. n = 3 for each sample.
Animal studies
All animal studies were conducted in accordance with protocols approved by the Washington University Animal Studies Committee. Mice were purchased from Charles River Laboratory.
Determination of pH changes in vivo post bolus particle intravenous injection -HT1080 tumors were grown subcutaneously in dorsal flanks of athymic nude mice, in dorsal bilateral flanks. Tumors generally grew in one flank. When the tumors growth reaches approximately 50 mm 3 or greater, the pH was measured using an external pH electrode.
Prior to these experiments, the mice had daily I.V. CaCO 3 (1 mg) treatments for 3 weeks. Treatments were discontinued for at least 5 days before performing the in vivo pH measurements. The average initial pH was 6.94 +/− 0.147.
The pH electrode was calibrated before implanting into the tumor and measurements were recorded following a 15-minute equilibration period after implantation. About 1 mg of each size of particles (20 nm, 100 nm, 300 nm) in a 100 μL solution consisting of PBS, CaCl 2 , MgCl 2 and 2% bovine serum albumin was injected intravenously in individual mice. Approximately 100 μL of aqueous vector (PBS, CaCl 2 , MgCl 2 , and 2% bovine serum albumin), 100 μL of 0.84% sodium bicarbonate in deionized (dI) water, and 100 μL of 7.5% sodium bicarbonate in dI water were each serially injected intravenously into the same mouse with 1 h gaps for measurement. Tumor sizes at time of injection for this experiment were 12 mm x 9 mm (20 nm particles), 13.7 mm x 12.5 mm (100 nm), 13.5 mm x 15.5 mm (300 nm), 12.5 x 16.5 mm (.84% bicarbonate), 12.5 x 16.5 mm (7.5% bicarbonate), and 12.5 x 16.5 mm (vector). In general, the pH was then followed each minute for a minimum of 1 h, or up to 3 h if any changes were seen. Animals could tolerate this pH measurement procedure for approximately 4 h and exhibits complete recovery after treatment. Bleeding, if any, was also noted. Determination of tumor growth after CaCO3 administration-HT1080 tumors were grown subcutaneously in the dorsal flanks of six athymic nude mice (age ~ 8-10 weeks). After tumor growth reached about 100 mm 3 , I.V. treatment with nano-CaCO 3 was initiated for three mice. About 1 mg of particles (100 nm) in 100 μL of a solution consisting of PBS, CaCl 2 , MgCl 2 , and 20 mg/mL of albumin was injected I.V. every 24 h for 5 days in three mice. The tumor size was measured for each day concurrently between treated and control for 12 days. The pH in the tumor region was then measured for each mouse as described above. During analysis, tumors that were considered too small to measure but deemed palpable, were assigned the largest size measured on Day 1 (50 mm 3 ) as a conservative estimate. 
Measurement of pH increases post multiple injections-HT1080
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